![Claudio Nessi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claudio Nessi
Président chez
Calliditas Therapeutics Suisse SA
Profil
Claudio Nessi is currently Chairman at Calliditas Therapeutics Suisse SA and Chord Therapeutics SA. Managing Director at Omega Fund Management LLC since 2016.
Director at Avitide, Inc., SoniVie Ltd., Anaconda Biomed SL, Nuvation Bio Operating Co., Inc., CDR-Life AG.
Non-Executive Director at NRG Therapeutics Ltd. Partner at Neomed Management AS.
Managing Partner at NeoMed S.à.r.l.
since 2017.
Formerly Chairman at Calliditas Therapeutics France SAS. Director at EUSA Pharma, Inc., ENDOSENSE SA, Creabilis SA. Independent Director at Arsanis, Inc. from 2013 to 2019.
Director-Executive Board at Axovan AG and PregLem SA from 2010 to 2013.
Non-Executive Director at Creabilis Therapeutics Srl and Creabilis Holdings Ltd. from 2013 to 2016.
Director at Creabilis UK Ltd. from 2008 to 2016.
Member-Management Board at Kuros Biosurgery Holding AG.
Venture Partner at REFERENCE CAPITAL SA from 2000 to 2001.
Education includes an MBA from Erasmus University Rotterdam in 2001, a doctorate from the University of Pavia in 1995, and a graduate degree from the University of Lausanne in 1991.
Postes actifs de Claudio Nessi
| Sociétés | Poste | Début |
|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Président | - |
NeoMed S.à.r.l.
 NeoMed S.à.r.l. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/03/2001 |
Avitide, Inc.
 Avitide, Inc. BiotechnologyHealth Technology Develops affinity purification solutions | Directeur/Membre du Conseil | - |
Anaconda Biomed SL
 Anaconda Biomed SL Medical SpecialtiesHealth Technology Manufactures healthcare devices | Directeur/Membre du Conseil | - |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Private Equity Investor | 01/01/2016 |
Chord Therapeutics SA
 Chord Therapeutics SA BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company which develops drugs for patients with life-threatening and severely disabling diseases | Président | - |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Directeur/Membre du Conseil | - |
CDR-Life Inc.
 CDR-Life Inc. BiotechnologyHealth Technology Operates as a biotherapeutics company | Directeur/Membre du Conseil | - |
NRG Therapeutics Ltd.
 NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops breakthrough solutions for neurodegenerative disorders | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Claudio Nessi
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Claudio Nessi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Kuros Biosurgery Holding AG
 Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs for biosurgery, tissue repair and regeneration | Commercial Services |
Axovan AG
 Axovan AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
REFERENCE CAPITAL SA
 REFERENCE CAPITAL SA Investment ManagersFinance Genevest's portfolio of investments has reached maturity. The firm primarily oversees exit operations through trade sales and IPOs. Their past investments focused on sectors such as IT, communications, materials science, medical technology and life sciences, primarily in Europe and selectively in the US and Israel. The firm typically holds minority stakes in syndication with other investors, and generally does not sit on the board of their portfolio companies. | Finance |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pavia
 University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neomed Management AS
 Neomed Management AS Investment ManagersFinance NeoMed utilizes a multi-stage investment approach and aims for growth of their portfolio firms. They invest at all development stages, from start-up to later stage growth financings. They have an investment horizon that spans three to five years. They focus on investments in the healthcare and life science sectors in the US and Europe, in particular in the Nordic region and Switzerland, Germany and the UK. Initial investments typically range from $2.5 million to $5 million. They normally invest with other venture capital partners that share a similar investment approach and vision. NeoMed seeks firms developing innovative products that address underserved medical needs in the following sectors: biotechnology drugs, diagnostics, pharmaceuticals, and medical devices and instruments. They look for intellectual property that is patent protected or benefits from other protective measures. The firm invests in firms with experienced management teams. | Finance |
NeoMed S.à.r.l.
NeoMed S.à.r.l. Investment ManagersFinance Functions as an alternative investment manager | Finance |
ENDOSENSE SA
 ENDOSENSE SA Medical SpecialtiesHealth Technology Operates as a medical technology company which focuses on reproducibility of catheter ablation for the treatment of cardiac arrhythmias | Health Technology |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Health Technology |
Creabilis Therapeutics Srl
 Creabilis Therapeutics Srl Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
Creabilis Holdings Ltd.
 Creabilis Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Avitide, Inc.
Avitide, Inc. BiotechnologyHealth Technology Develops affinity purification solutions | Health Technology |
SoniVie Ltd.
 SoniVie Ltd. Medical SpecialtiesHealth Technology Develops intravascular ultrasound systems | Health Technology |
Anaconda Biomed SL
Anaconda Biomed SL Medical SpecialtiesHealth Technology Manufactures healthcare devices | Health Technology |
Creabilis SA | |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development | Commercial Services |
Creabilis UK Ltd.
 Creabilis UK Ltd. BiotechnologyHealth Technology Engages in research and development of biological products | Health Technology |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Chord Therapeutics SA
Chord Therapeutics SA BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company which develops drugs for patients with life-threatening and severely disabling diseases | Health Technology |
CDR-Life Inc.
CDR-Life Inc. BiotechnologyHealth Technology Operates as a biotherapeutics company | Health Technology |
NRG Therapeutics Ltd.
NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops breakthrough solutions for neurodegenerative disorders | Commercial Services |
